Publications

• Salvage therapies for first relapse of SHH medulloblastoma in early childhood.
  Neuro Oncol
  04/04/2025 Authors: Erker C; Mynarek M; Simbozel M; Craig BT; Harrod VL; Cappellano AM; Cohen KJ; Lopez VS-M; Morales-La Madrid A; Cacciotti C
• Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions.
  Clin Cancer Res Volume: 31 Page(s): 561 - 572
  02/03/2025 Authors: Lamoureux A-A; Fisher MJ; Lemelle L; Pfaff E; Amir-Yazdani P; Kramm C; De Wilde B; Kazanowska B; Hutter C; Pfister SM
• Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma.
  Neuro Oncol Volume: 26 Page(s): S155 - S164
  05/03/2024 Authors: Odia Y; Koschmann C; Vitanza NA; de Blank P; Aguilera D; Allen J; Daghistani D; Hall M; Khatib Z; Kline C
• ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.
  J Clin Oncol Volume: 42 Page(s): 1542 - 1552
  05/01/2024 Authors: Arrillaga-Romany I; Gardner SL; Odia Y; Aguilera D; Allen JE; Batchelor T; Butowski N; Chen C; Cloughesy T; Cluster A
• Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial.
  Neuro Oncol Volume: 26 Page(s): 348 - 361
  02/02/2024 Authors: Johnson TS; MacDonald TJ; Pacholczyk R; Aguilera D; Al-Basheer A; Bajaj M; Bandopadhayay P; Berrong Z; Bouffet E; Castellino RC
• Primary Diffuse Leptomeningeal Melanomatosis in a Child with Extracranial Metastasis: Case Report.
  Curr Oncol Volume: 31 Page(s): 579 - 587
  01/20/2024 Authors: Shahab SW; Patil P; Fangusaro JR; Patteson B; Goldman-Yassen A; Eaton BR; Boydston W; Schniederjan M; Aguilera D
• A Pilot Study Omitting Radiation in the Treatment of Children with Newly Diagnosed Wnt-Activated Medulloblastoma.
  Clin Cancer Res Volume: 29 Page(s): 5031 - 5037
  12/15/2023 Authors: Cohen KJ; Munjapara V; Aguilera D; Castellino RC; Stapleton SL; Landi D; Ashley DM; Rodriguez FJ; Hawkins C; Yang E
• A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors.
  Volume: 70 Page(s): e30405
  08/01/2023 Authors: Cash T; Jonus HC; Tsvetkova M; Beumer JH; Sadanand A; Lee JY; Henry CJ; Aguilera D; Harvey RD; Goldsmith KC
• Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study.
  J Clin Oncol Volume: 41 Page(s): 1921 - 1932
  04/01/2023 Authors: Erker C; Mynarek M; Bailey S; Mazewski CM; Baroni L; Massimino M; Hukin J; Aguilera D; Cappellano AM; Ramaswamy V
• Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor.
  Neuro Oncol Volume: 25 Page(s): 386 - 397
  02/14/2023 Authors: Upadhyaya SA; Campagne O; Billups CA; Orr BA; Onar-Thomas A; Tatevossian RG; Mostafavi R; Myers JR; Vinitsky A; Moreira DC
• Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics.
  Neuro Oncol Volume: 25 Page(s): 199 - 210
  01/05/2023 Authors: Yeo KK; Alexandrescu S; Cotter JA; Vogelzang J; Bhave V; Li MM; Ji J; Benhamida JK; Rosenblum MK; Bale TA
• Case report: ATIC-ALK fusion in infant-type hemispheric glioma and response to lorlatinib.
  Front Oncol Volume: 13 Page(s): 1123378
  01/01/2023 Authors: Shahab SW; Schniederjan M; Vega JV; Little S; Reisner A; MacDonald T; Aguilera D
• Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma.
  Neuro Oncol Volume: 24 Page(s): 1964 - 1975
  11/02/2022 Authors: Rosenberg T; Yeo KK; Mauguen A; Alexandrescu S; Prabhu SP; Tsai JW; Malinowski S; Joshirao M; Parikh K; Farouk Sait S
• REMISSION OF HYPOTHALAMIC OBESITY IN PEDIATRIC-ONSET CRANIOPHARYNIOMA DURING INTERFERON-BASED TUMOR TREATMENT
  Volume: 69 Page(s): S296 - S297
  11/01/2022 Authors: Patterson B; Gray R; Mazewski C; Aguilera D; Craig R; Patil P; Janss A
• FIRST-IN-CHILDREN PHASE 1 TRIAL OF INDOXIMOD-BASED CHEMO-IMMUNOTHERAPY FOR PATIENTS WITH PEDIATRIC BRAIN TUMORS: ANALYSIS OF SAFETY, TOLERABILITY, AND 5-YEAR OUTCOME
  Volume: 24 Page(s): 68 - 68
  11/01/2022 Authors: Johnson T; Pacholczyk R; Aguilera D; Al-Basheer A; Bajaj M; Bandopadhayay P; Berrong Z; Bouffet E; Castellino R; Dorris K
• UPFRONT MOLECULAR TARGETED THERAPY FOR THE TREATMENT OF BRAF-MUTANT PEDIATRIC HIGH-GRADE GLIOMA
  Volume: 24 Page(s): 68 - 68
  06/01/2022 Authors: Rosenberg T; Yeo KK; Mauguen A; Alexandrescu S; Prabhu SP; Tsai JW; Malinowski S; Joshirao M; Parikh K; Sait SF
• THE USE OF SUBCUTANEOUS INTERFERON IN PATIENTS WITH CRANIOPHARYNGIOMA: AN INSTITUTIONAL RETROSPECTIVE REVIEW
  Volume: 24 Page(s): 15 - 16
  06/01/2022 Authors: Patil P; Gray R; Goldman-Yassen A; Aguilera D; Castellino R; Janss A; Mazewski C
• A PHASE II STUDY OF PEGYLATED INTERFERON IN CHILDREN WITH RECURRENT OR REFRACTORY AND RADIOGRAPHICALLY OR CLINICALLY PROGRESSIVE JUVENILE PILOCYTIC ASTROCYTOMAS AND OPTIC PATHWAY GLIOMAS (NCT02343224)
  Volume: 24 Page(s): 103 - 103
  06/01/2022 Authors: Aguilera D; Mazewski C; Janss A; MAcDonald T; Goldman A; Leong T; Castellino RC
• CLINICAL CHARACTERISTICS AND CLINICAL EVOLUTION OF A LARGE COHORT OF PEDIATRIC PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS AND TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION.
  Volume: 24 Page(s): 61 - 62
  06/01/2022 Authors: Lamoureux A-A; Fisher M; Lemelle L; Pfaff E; Kramm C; De Wilde B; Kazanowska B; Hutter C; Pfister SM; Sturm D
• Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy.
  Neurooncol Adv Volume: 4 Page(s): vdac143
  01/01/2022 Authors: Gardner SL; Tarapore RS; Allen J; McGovern SL; Zaky W; Odia Y; Daghistani D; Diaz Z; Hall MD; Khatib Z
• UPFRONT TARGETED THERAPY FOR THE TREATMENT OF BRAFV600E-MUTANT PEDIATRIC HIGH-GRADE GLIOMA - A MULTI-INSTITUTIONAL EXPERIENCE
  Volume: 23 Page(s): 25 - 25
  06/01/2021 Authors: Rosenberg T; Yeo KK; Joshirao M; Michaiel G; Hung T; Dahiya S; Kachurak K; Friedman G; Huang M; Wright K
• BINIMETINIB IN CHILDREN WITH PROGRESSIVE OR RECURRENT LOW-GRADE GLIOMA NOT ASSOCIATED WITH NEUROFIBROMATOSIS TYPE 1: INITIAL RESULTS FROM A MULTI-INSTITUTIONAL PHASE II STUDY
  Volume: 22 Page(s): 376 - 376
  12/01/2020 Authors: Robison N; Pauly J; Malvar J; Gardner S; Allen J; MacDonald T; Aguilera D; Baxter P; Bendel A; Kilburn L
• PHASE I CLINICAL TRIAL OF ONC201 IN PEDIATRIC H3 K27M-MUTANT GLIOMA OR NEWLY DIAGNOSED DIPG
  Volume: 22 Page(s): 297 - 297
  12/01/2020 Authors: Gardner S; Tarapore R; Allen J; Zaky W; Odia Y; Hall M; Daghistani D; Khatib Z; Koschmann C; Aguilera D
• CAN YOUNG CHILDREN WITH RELAPSED MEDULLOBLASTOMA BE SALVAGED AFTER INITIAL IRRADIATION-SPARING APPROACHES?
  Volume: 22 Page(s): 139 - 140
  11/01/2020 Authors: Erker C; Larouche V; Aguilera D; Margol A; Cacciotti C; Perreault S; Cohen KJ; AbdelBaki M; Hukin J; Rassekh SR
• CLINICAL EFFICACY OF ONC201 IN NEWLY DIAGNOSED DIPG AND IN PREVIOUSLY IRRADIATED PEDIATRIC H3 K27M-MUTANT GLIOMAS
  Volume: 22 Page(s): 45 - 45
  11/01/2020 Authors: Gardner S; Koschmann C; Tarapore RS; Allen J; Zaky W; Odia Y; Hall M; Daghistani D; Khatib Z; Aguilera D
• ONC201 in previously irradiated pediatric H3 K27M-mutant glioma or newly diagnosed DIPG.
  Volume: 38
  05/20/2020 Authors: Gardner SL; Koschmann CJ; Tarapore R; Allen JC; Zaky WT; Odia Y; Hall M; Daghistani D; Khatib Z; Aguilera D
• Phase 1 study of abemaciclib in children with recurrent and refractory solid tumors including malignant brain tumors
  Volume: 18
  12/01/2019 Authors: Cash T; Aguilera D; Macy ME; Hoffman L; Dorris K; McCracken C; Hanberry B; Castellino R; MacDonald T; Wetmore C
• Results of the NLG2105 phase I trial using the IDO pathway inhibitor indoximod, in combination with radiation and chemotherapy, for children with newly diagnosed DIPG
  Volume: 30 Page(s): 38 - 38
  12/01/2019 Authors: Johnson TS; Aguilera D; Al-Basheer A; Berrong Z; Castellino RC; Eaton BR; Esiashvili N; Foreman N; Heger IM; Kennedy EP
• PHASE I CLINICAL TRIAL OF ONC201 IN PEDIATRIC H3 K27M-MUTANT GLIOMA OR NEWLY DIAGNOSED DIPG
  Volume: 21 Page(s): 185 - 185
  11/01/2019 Authors: Gardner S; Tarapore R; Allen J; Zaky W; Odia Y; Hall M; Daghistani D; Khatib Z; Koschmann C; Aguilera D
• A PHASE II TRIAL OF POLY-ICLC IN THE MANAGEMENT OF RECURRENT OR PROGRESSIVE PEDIATRIC LOW GRADE GLIOMAS. RESULTS FOR THE NEUROFIBROMATOSIS 1 GROUP. (NCT01188096)
  Volume: 20 Page(s): 201 - 201
  11/01/2018 Authors: Aguilera D; MacDonald T; Castellino R; Janss A; Mazewski C; Kadom N; Pu M; Messer K; Crawford J; Connelly E
• Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma.
  Neuro Oncol Volume: 20 Page(s): 1547 - 1555
  10/09/2018 Authors: Gupta N; Goumnerova LC; Manley P; Chi SN; Neuberg D; Puligandla M; Fangusaro J; Goldman S; Tomita T; Alden T
• LATE ONSET OR ATYPICAL ADRENAL INSUFFICIENCY DUE TO ACTH DEFICIENCY IN SURVIVORS OF NON-PITUITARY BRAIN TUMORS
  Volume: 20 Page(s): 165 - 165
  06/01/2018 Authors: Wu M; Mazewski C; Aguilera D; Esiashvili N; Patterson B
• RADIO-IMMUNOTHERAPY USING THE IDO PATHWAY INHIBITOR INDOXIMOD FOR CHILDREN WITH NEWLY-DIAGNOSED DIPG
  Volume: 20 Page(s): 103 - 104
  06/01/2018 Authors: Johnson TS; Aguilera D; Al-Basheer A; Castellino C; Eaton BR; Esiashvili N; Foreman N; Heger IM; Kennedy EP; Link CJ
• SUCCESSFUL TREATMENT OF A SECONDARY PEDIATRIC HIGH GRADE GLIOMA WITH A NOVEL BEND4-NTRK2 FUSION WITH ENTRECTINIB, A TRK INHIBITOR
  Volume: 20 Page(s): 67 - 67
  06/01/2018 Authors: Felker J; Philbrook B; Schneiderjan M; Chern J; Mazewski C; Eaton B; Chow-Maneval E; MacDonald T; Aguilera D
• A PHASE II TRIAL OF POLY-ICLC IN THE MANAGEMENT OF RECURRENT OR PROGRESSIVE PEDIATRIC LOW GRADE GLIOMAS (NCT01188096): PRELIMINARY ANALYSIS
  Volume: 20 Page(s): 116 - 117
  06/01/2018 Authors: Aguilera D; MacDonald T; Crawford J; Kadom N; Janss A; Mazewski C; Castellino RC; Gray R; Pu M; Connelly E
• Clinical responses of patients with diffuse leptomeningeal glioneuronal tumors to chemotherapy.
  Childs Nerv Syst Volume: 34 Page(s): 329 - 334
  02/01/2018 Authors: Aguilera D; Castellino RC; Janss A; Schniederjan M; McNall R; MacDonald T; Mazewski C
• FEASIBILITY AND SAFETY OF SURGICAL BIOPSY FOR PATIENTS WITH DIPG: PRELIMINARY RESULTS FROM DIPG-BATS
  Volume: 19 Page(s): 188 - 188
  11/01/2017 Authors: Gupta N; Goumnerova L; Ayyanar K; Gump W; Bendel A; Nagib M; Bowers D; Weprin B; Bredlau A-L; Gururangan S
• RADIO-IMMUNOTHERAPY USING THE IDO-INHIBITOR INDOXIMOD IN COMBINATION WITH RE-IRRADIATION FOR CHILDREN WITH PROGRESSIVE BRAIN TUMORS IN THE PHASE 1 SETTING: AN UPDATED REPORT OF SAFETY AND TOLERABILITY (NCT02502708)
  Volume: 19 Page(s): 185 - 185
  11/01/2017 Authors: Johnson TS; Aguilera D; Al-Basheer A; Cooksey RM; Eaton BR; Esiashvili N; Firat S; Fiveash JB; Foreman N; Fridlyand D
• FEASIBILITY AND SAFETY OF SURGICAL BIOPSY FOR PATIENTS WITH DIPG: PRELIMINARY RESULTS FROM DIPG-BATS
  Volume: 19 Page(s): 56 - 56
  06/01/2017 Authors: Gupta N; Goumnerova L; Ayyanar K; Gump W; Bendel A; Nagib M; Bowers D; Weprin B; Bredlau A-L; Gururangan S
• GENOMIC LANDSCAPE OF DIFFUSE INTRINSIC PONTINE GLIOMA: AN ANALYSIS OF THE DIPG-BATS COHORT
  Volume: 19 Page(s): 11 - 11
  06/01/2017 Authors: Bandopadhayay P; Greenwald NF; Wala J; Sharpira O; Tracy A; Filbin M; O'Rourke R; Ho P; Sinai C; Malkin H
• Successful Retreatment of a Child with a Refractory Brainstem Ganglioglioma with Vemurafenib.
  Pediatr Blood Cancer Volume: 63 Page(s): 541 - 543
  03/01/2016 Authors: Aguilera D; Janss A; Mazewski C; Castellino RC; Schniederjan M; Hayes L; Brahma B; Fogelgren L; MacDonald TJ
• Response of subependymal giant cell astrocytoma with spinal cord metastasis to everolimus.
  J Pediatr Hematol Oncol Volume: 36 Page(s): e448 - e451
  10/01/2014 Authors: Aguilera D; Flamini R; Mazewski C; Schniederjan M; Hayes L; Boydston W; Castellino RC; MacDonald TJ
• RECURRENT GANGLIOGLIOMA WITH BRAF V600E MUTATION RESPONSE TO VEMURAFENIB: CASE REPORT
  Volume: 16 Page(s): 61 - 61
  06/01/2014 Authors: Aguilera D; Mazewski C; Janss A; Castellino RC; Schniederjan M; Hayes L; Brahma B; MacDonald T
• MORAL DISTRESS IN PEDIATRIC HEMATOLOGY/ONCOLOGY PHYSICIANS
  PEDIATRIC BLOOD & CANCER Volume: 61 Page(s): S32 - S32
  05/01/2014 Authors: Aguilera D; Castellino R; Kim S; Woods W; Trotochaud K
• The rationale for targeted therapies in medulloblastoma.
  Neuro Oncol Volume: 16 Page(s): 9 - 20
  01/01/2014 Authors: MacDonald TJ; Aguilera D; Castellino RC
• Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience.
  Childs Nerv Syst Volume: 29 Page(s): 589 - 596
  04/01/2013 Authors: Aguilera D; Mazewski C; Fangusaro J; MacDonald TJ; McNall-Knapp RY; Hayes LL; Kim S; Castellino RC
• Prolonged survival after treatment of diffuse intrinsic pontine glioma with radiation, temozolamide, and bevacizumab: report of 2 cases.
  J Pediatr Hematol Oncol Volume: 35 Page(s): e42 - e46
  01/01/2013 Authors: Aguilera DG; Mazewski C; Hayes L; Jordan C; Esiashivilli N; Janns A; Macdonald TJ
• Drop metastases to the pediatric spine revealed with diffusion-weighted MR imaging.
  Pediatr Radiol Volume: 42 Page(s): 1009 - 1013
  08/01/2012 Authors: Hayes LL; Jones RA; Palasis S; Aguilera D; Porter DA
• SUBEPENDYMAL GIANT CELL ASTROCYTOMA OF THE SPINAL CORD AND RESPONSE TO EVEROLIMUS
  Volume: 14 Page(s): 155 - 156
  06/01/2012 Authors: Aguilera D; Flamini R; Mazewski C; Schniederjan M; Hayes L; Boydston W; MacDonald T
• DROP METASTASES REVEALED WITH DIFFUSION-WEIGHTED IMAGING OF THE SPINE
  Volume: 14 Page(s): 143 - 144
  06/01/2012 Authors: Hayes L; Jones R; Mazewski C; Aguilera D; Palasis S
• RESPONSE TO BEVACIZUMAB, IRINOTECAN, AND TEMOZOLAMIDE IN RECURRENT EMBRYONAL TUMORS: A MULTI-INSTITUTIONAL EXPERIENCE
  Volume: 14 Page(s): 20 - 20
  06/01/2012 Authors: Aguilera D; Mazewski C; Fangusaro J; MacDonald T; McNall R; Hayes L; Liu Y; Castellino R
• THE ROLE OF p63 IN THE RESPONSE OF MEDULLOBLASTOMA CELLS TO GENOTOXIC STRESS
  NEURO-ONCOLOGY Volume: 13 Page(s): 117 - 118
  11/01/2011 Authors: Gopalakrishnan V; Das C; Taylor P; Kommagani R; Su X; Aguilera D; Thomas A; Wolff J; Flores E; Kadakia M
• Treatment of high-grade glioma in children and adolescents.
  Neuro Oncol Volume: 13 Page(s): 1049 - 1058
  10/01/2011 Authors: MacDonald TJ; Aguilera D; Kramm CM
• Evaluating the incidence and utility of microscopic metastatic dissemination as diagnosed by lumbar cerebro-spinal fluid (CSF) samples in children with newly diagnosed intracranial ependymoma.
  J Neurooncol Volume: 103 Page(s): 693 - 698
  07/01/2011 Authors: Fangusaro J; Van Den Berghe C; Tomita T; Rajaram V; Aguilera D; Wang D; Goldman S
• RESPONSES IN PATIENTS WITH NEW DIAGNOSIS OF DIFFUSE INTRINSIC PONTINE GLIOMA: REPORT ON TWO CASES TREATED WITH RADIATION, TEMOZOLAMIDE AND BEVACIZUMAB
  PEDIATRIC BLOOD & CANCER Volume: 56 Page(s): 962 - 962
  06/01/2011 Authors: Aguilera D; Mazewski C; Eshivilli N; Hayes L; Jordan C; Macdonald T
• Neurofibromatosis-2 and spinal cord ependymomas: Report of two cases and review of the literature.
  Childs Nerv Syst Volume: 27 Page(s): 757 - 764
  05/01/2011 Authors: Aguilera DG; Mazewski C; Schniederjan MJ; Leong T; Boydston W; Macdonald TJ
• Bevacizumab and irinotecan in the treatment of children with recurrent/refractory medulloblastoma.
  Pediatr Blood Cancer Volume: 56 Page(s): 491 - 494
  03/01/2011 Authors: Aguilera DG; Goldman S; Fangusaro J
• INCIDENTAL RESOLUTION OF A RADIATION-INDUCED CAVERNOUS HEMANGIOMA (RICH) OF THE BRAIN FOLLOWING THE USE OF BEVACIZUMAB IN A CHILD WITH RECURRENT MEDULLOBLASTOMA
  Volume: 12 Page(s): 82 - 82
  11/01/2010 Authors: Aguilera D; Goldman S; Tomita T; Fangusaro J
• VPA UPREGULATES P63 EXPRESSION AND SENSITIZES MEDULLOBLASTOMA CELLS TO ETOPOSIDE-MEDIATED APOPTOSIS
  Volume: 12 Page(s): 86 - 86
  11/01/2010 Authors: Das CM; Taylor P; Su X; Kommagani R; Aguilera DG; Wolff JE; Kadakia MP; Flores ER; Gopalakrishnan V
• HISTONE DEACETYLASE INHIBITORS PROMOTE DEGRADATION OF THE RE-1 SILENCING TRANSCRIPTION FACTOR AND NEURONAL DIFFERENTIATION IN MEDULLOBLASTOMA
  Volume: 12 Page(s): 86 - 86
  11/01/2010 Authors: Taylor P; Kang N; Das CM; Rajaram V; Aguilera DG; Goldman S; Fangusaro J; Gopalakrishnan V
• Chromatin remodelling at the topoisomerase II-beta promoter is associated with enhanced sensitivity to etoposide in human neuroblastoma cell lines.
  Eur J Cancer Volume: 46 Page(s): 2771 - 2780
  10/01/2010 Authors: Das CM; Zage PE; Taylor P; Aguilera D; Wolff JEA; Lee D; Gopalakrishnan V
• EVALUATING THE UTILITY OF LUMBAR CEREBRO-SPINAL FLUID (CSF) SAMPLES IN CHILDREN WITH NEWLY DIAGNOSED INTRACRANIAL EPENDYMOMA: THE CHICAGO CHILDREN'S MEMORIAL HOSPITAL EXPERIENCE
  Volume: 12 Page(s): II27 - II27
  06/01/2010 Authors: Fangusaro J; Van den Berghe C; Tomita T; Rajaram V; Aguilera D; Goldman S
• Incidental resolution of a radiation-induced cavernous hemangioma of the brain following the use of bevacizumab in a child with recurrent medulloblastoma.
  Pediatr Neurosurg Volume: 46 Page(s): 303 - 307
  01/01/2010 Authors: Aguilera D; Tomita T; Goldman S; Fangusaro J
• Glioblastoma multiforme in a patient with chronic granulomatous disease treated with subtotal resection, radiation, and thalidomide: case report of a long-term survivor.
  J Pediatr Hematol Oncol Volume: 31 Page(s): 965 - 969
  12/01/2009 Authors: Aguilera DG; Tomita T; Rajaram V; Fangusaro J; Katz BZ; Shulman S; Goldman S
• Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience.
  J Pediatr Hematol Oncol Volume: 31 Page(s): 803 - 811
  11/01/2009 Authors: Aguilera DG; Vaklavas C; Tsimberidou AM; Wen S; Medeiros LJ; Corey SJ
• REST EXPRESSION AND ITS PROGNOSTIC RELEVANCE IN EPENDYMOMAS
  Volume: 11 Page(s): 652 - 652
  10/01/2009 Authors: Aguilera DG; Rajaram V; Fangusaro J; Tomita T; Gopalakrishnan V; Wen S; Goldman S
• PROLONGED PROGRESSION-FREE SURVIVAL IN TWO PEDIATRIC PATIENTS WITH RECURRENT/REFRACTORY MEDULLOBLASTOMA TREATED WITH A COMBINATION OF BEVACIZUMAB AND IRINOTECAN
  Volume: 11 Page(s): 637 - 637
  10/01/2009 Authors: Fangusaro J; Goldman S; Aguilera DG
• Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL.
  J Neurooncol Volume: 93 Page(s): 303 - 318
  07/01/2009 Authors: Aguilera DG; Das CM; Sinnappah-Kang ND; Joyce C; Taylor PH; Wen S; Hasselblatt M; Paulus W; Fuller G; Wolff JE
• ATRT: Importance of BAF47 and Therapeutic Update
  Volume: 68 Page(s): 567 - 567
  05/01/2009 Authors: Aguilera D; Goldman S; Rajaram V
• Congenital/Pediatric Glioblastoma Multiforme or Primitive Neuroectodermal Tumor?
  Volume: 68 Page(s): 582 - 582
  05/01/2009 Authors: Rajaram V; Aguilera D; Goldman S
• Dasatinib in chronic myeloid leukemia: a review.
  Ther Clin Risk Manag Volume: 5 Page(s): 281 - 289
  04/01/2009 Authors: Aguilera DG; Tsimberidou AM
• Outpatient and home chemotherapy with novel local control strategies in desmoplastic small round cell tumor.
  Sarcoma Volume: 2008 Page(s): 261589
  01/01/2008 Authors: Aguilera D; Hayes-Jordan A; Anderson P; Woo S; Pearson M; Green H
• Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents.
  Cancer Control Volume: 15 Page(s): 38 - 46
  01/01/2008 Authors: Anderson P; Aguilera D; Pearson M; Woo S
• Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines.
  J Neurooncol Volume: 85 Page(s): 159 - 170
  11/01/2007 Authors: Das CM; Aguilera D; Vasquez H; Prasad P; Zhang M; Wolff JE; Gopalakrishnan V
• Valproic acid sensitizes high grade glioma cells to etoposide
  PEDIATRIC BLOOD & CANCER Volume: 49 Page(s): 440 - 440
  10/01/2007 Authors: Gopalakrishnan V; Anderson P; Das C; Aguilera D; Vasquez H; Prasad P; Zhang M; Wolff J
• Resolving inconsistency of synergy detection at different time points
  Volume: 9 Page(s): 534 - 534
  10/01/2007 Authors: Zhang M; Das C; Aguilera D; Kang N; Gopalakrishnan V; Wolf J
• The histone deacetylase inhibitor, MS-275 up-regulates FAS, DR4, and DR5 expression and activates the death receptor pathway in medulloblastoma cells
  Volume: 9 Page(s): 561 - 561
  10/01/2007 Authors: Aguilera D; Sinnappah-Kang N; Wolff J; Gopalakrishnan V
• Valproic acid enhances etoposide induced cytotoxicity in neuroblastoma cells
  Volume: 25
  06/20/2007 Authors: Aguilera DG; Das C; Wolff J; Zage P; Gopalakrishnan V
• Demethylating agents and histone deacetylase inhibitors in medulloblastoma
  Volume: 9 Page(s): 197 - 197
  04/01/2007 Authors: Aguilera D; Vasquez H; Das C; Gopalakrishnan V; Wolff J
• Measuring cytotoxicity: a new perspective on LC50.
  Anticancer Res Volume: 27 Page(s): 35 - 38
  01/01/2007 Authors: Zhang M; Aguilera D; Das C; Vasquez H; Zage P; Gopalakrishnan V; Wolff J
• A two-term exponential model for tumor repopulation after response
  Volume: 8 Page(s): 474 - 474
  10/01/2006 Authors: Zhang M; Das C; Vasquez H; Aguilera D; Gopalakrishnan V; Zage P; Wolff J
• Rest: A novel, therapeutic target for medulloblastomas
  Volume: 8 Page(s): 465 - 465
  10/01/2006 Authors: Aguilera D; Khang N; Wolff J; Majumder S; Gopalakrishnan V
• Effect of the HDAC inhibitor MS-275 on medulloblastoma growth and viability
  Volume: 8 Page(s): 465 - 465
  10/01/2006 Authors: Aguilera DG; Zage P; Wolff J; Gopalakrishan V
• Predicting tumor cell repopulation after response: mathematical modeling of cancer cell growth.
  Anticancer Res Volume: 26 Page(s): 2933 - 2936
  01/01/2006 Authors: Zhang M; Das C; Vasquez H; Aguilera D; Zage PE; Gopalakrishnan V; Wolff JE